
|
SGLT2 Inhibitors and Ketoacidosis: Pathophysiology and Management
Yun Hyi Ku
Korean J Med. 2017;92(5):443-449. Published online 2017 Oct 1 DOI: https://doi.org/10.3904/kjm.2017.92.5.443
|
|
Citations to this article as recorded by
|